Pharma Tips

FDA 'No' for Gilead HIV Drugs Elvitegravir and Cobicistat

By: Pharma News | Views: 1449 | Date: 03-May-2013

Gilead Sciences has suffered a setback after regulators in the USA rejected two of the components of its four-in-one HIV drug Stribild as stand-alone therapies.


FDA 'No' for Gilead HIV Drugs Elvitegravir and Cobicistat

FDA News

Gilead Sciences has suffered a setback after regulators in the USA rejected two of the components of its four-in-one HIV drug Stribild as stand-alone therapies.

The company received complete response letters from the US Food and Drug Administration for its submissions of elvitegravir and cobicistat. The agency says that it cannot approve the applications in their current forms, noting that during recent inspections, “deficiencies in documentation and validation of certain quality testing procedures and methods were observed".

Gilead said it is working with FDA to address the questions raised in the CRLs. The two drugs are components in the once-daily single-tablet Stribild, along with emtricitabine and tenofovir, which was approved in the USA last August. The company stressed that the CRLs do not affect the marketing authorization or continued use of Stribild.

Analysts are not too concerned about the CRLs as the drugs as monotherapies are not expected to have huge sales. However, Stribild is touted as a major $3 billion a year blockbuster.

 

 

Previous Page Next Page

People Searching On This Page:
  • elvitegravir drug in indian company
  • elvitegravir available in india
  • cobicistat in india
  • Elvitegravir in india
  • manufacturer cobicistat in India
  • in which indian company cobicistat drug is available
  • elvitegravir in indian market
  • elvitegravir available in indian pharmaceutical company
  • fda cobicistat gmp
  • cipla cobicistat
  • cobicistat apis from india

Related Pages


After IT, Trump targets pharma; says will name US FDA chief soon

After IT, Trump targets pharma; says will name US FDA chief soon

News
Date:
01-Feb-2017  Views: 4241

In what could be a blow to the Indian pharma industry, US President Donald Trump today said that other countries have been taking advantage of the US ...
NPPA cuts prices of malaria, HIV, cancer drugs by up to 45%

NPPA cuts prices of malaria, HIV, cancer drugs by up to 45%

News | NPPA
Date:
18-Nov-2016  Views: 759

Prices of 22 essential drugs used for treatment of cancer, HIV, bacterial infections and malaria among others, have been capped by the government, red ...
B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

Jobs | Drug Inspector
Date:
02-Mar-2016  Views: 22310

Online applications are invited from Indian Citizen and such other national as declared eligible by Government of India for recruitment to the 88 post ...
Diet Pill Dilemma: Why Is FDA Approving Drugs When Europe Isn’t?

Diet Pill Dilemma: Why Is FDA Approving Drugs When Europe Isn’t?

News | FDA
Date:
09-Sep-2013  Views: 1846

We’ve all dreamt of popping a pill to help us safely lose weight, or at least eat that chocolate cake without guilt. But alas, even though the Food an ...
Drugs Inspector Job Vacancy  in Drugs Control Department of KPSC

Drugs Inspector Job Vacancy in Drugs Control Department of KPSC

Jobs | Drug Inspector
Date:
05-Jul-2012  Views: 25102

Vacancy for Drugs Inspector in Drugs Control department of KPSC - Freshers may apply ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

45  + 1 =     
Comments
People Searched About:
Elvitegravir Drug In Indian Company   |   Elvitegravir Available In India   |   Cobicistat In India   |   Elvitegravir In India   |   Manufacturer Cobicistat In India   |   In Which Indian Company Cobicistat Drug Is Available   |   Elvitegravir In Indian Market   |  
Google : 257 times | Yahoo : 16 times | Bing : 34 times |